APVO - Aptevo Therapeutics GAAP EPS of -$1.23 misses by $0.11
2023-08-10 10:53:11 ET
- Aptevo Therapeutics press release ( NASDAQ: APVO ): Q2 GAAP EPS of -$1.23 misses by $0.11 .
- Aptevo had cash and cash equivalents as of June 30, 2023 totaling $21.0 million (exclusive of the proceeds from the equity raised closed on August 4, 2023).
For further details see:
Aptevo Therapeutics GAAP EPS of -$1.23 misses by $0.11